Anbio Biotechnology income statement data for the quarter ended Dec 2025. This income statement covers 4 quarters of results from Dec 2023 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2023 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|
| Additional items | ||||
| Shares Outstanding | 21.44M | 42.29M | 42.29M | 43.67M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 21.44M | 42.29M | 42.29M | 43.67M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 142.29M | 142.29M | 143.89M |